Dr Dean K Otaka, MD | |
98-1247 Kaahumanu St, Suite 115, Aiea, HI 96701-5311 | |
(808) 486-5556 | |
(808) 486-5586 |
Full Name | Dr Dean K Otaka |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 27 Years |
Location | 98-1247 Kaahumanu St, Aiea, Hawaii |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528079134 | NPI | - | NPPES |
0020533 | Other | HI | HMSA |
99-0358001 | Other | HI | HMA |
499138 | Other | HI | QUEST ALOHA CARE |
49913802 | Medicaid | HI | |
99-0358001 | Other | HI | HMAA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 10822 (Hawaii) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bristol Hospice - Hawaii, Llc | Honolulu, HI | Hospice |
Pali Momi Medical Center | Aiea, HI | Hospital |
The Queens Medical Center | Honolulu, HI | Hospital |
Entity Name | Dean K Otaka Md Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497853519 PECOS PAC ID: 4880694587 Enrollment ID: O20070108000079 |
News Archive
Today, Sentry Data Systems, Inc. announced its acquisition of Nashville-based Agilum Healthcare Intelligence. Sentry, the 2014 KLAS Category Leader for 340B Management Solutions, is a provider of SaaS-based technology and data analytics solutions that help healthcare organizations manage costs, compliance and outcomes.
OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Tarceva as monotherapy for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with stable disease following four cycles of standard platinum-based first-line chemotherapy.
University of Florida researchers have successfully used molecular probes to detect subtle differences in leukemia cells from patient samples, an achievement that could lead to more effective ways to diagnose and treat cancer.
Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems, one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme-an aggressive type of brain tumor.
Compared with erlotinib, treatment with afatinib leads to outcomes in previously treated patients with advanced squamous non-small-cell lung cancer, suggest the results of a head-to-head trial.
› Verified 2 days ago
Entity Name | Medical Office Force |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508378613 PECOS PAC ID: 9335481951 Enrollment ID: O20211012003040 |
News Archive
Today, Sentry Data Systems, Inc. announced its acquisition of Nashville-based Agilum Healthcare Intelligence. Sentry, the 2014 KLAS Category Leader for 340B Management Solutions, is a provider of SaaS-based technology and data analytics solutions that help healthcare organizations manage costs, compliance and outcomes.
OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Tarceva as monotherapy for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with stable disease following four cycles of standard platinum-based first-line chemotherapy.
University of Florida researchers have successfully used molecular probes to detect subtle differences in leukemia cells from patient samples, an achievement that could lead to more effective ways to diagnose and treat cancer.
Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems, one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme-an aggressive type of brain tumor.
Compared with erlotinib, treatment with afatinib leads to outcomes in previously treated patients with advanced squamous non-small-cell lung cancer, suggest the results of a head-to-head trial.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Dean K Otaka, MD Mail Code 61153 P.o.box 1300, Honolulu, HI 96807-1300 Ph: (808) 486-5556 | Dr Dean K Otaka, MD 98-1247 Kaahumanu St, Suite 115, Aiea, HI 96701-5311 Ph: (808) 486-5556 |
News Archive
Today, Sentry Data Systems, Inc. announced its acquisition of Nashville-based Agilum Healthcare Intelligence. Sentry, the 2014 KLAS Category Leader for 340B Management Solutions, is a provider of SaaS-based technology and data analytics solutions that help healthcare organizations manage costs, compliance and outcomes.
OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Tarceva as monotherapy for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with stable disease following four cycles of standard platinum-based first-line chemotherapy.
University of Florida researchers have successfully used molecular probes to detect subtle differences in leukemia cells from patient samples, an achievement that could lead to more effective ways to diagnose and treat cancer.
Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems, one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme-an aggressive type of brain tumor.
Compared with erlotinib, treatment with afatinib leads to outcomes in previously treated patients with advanced squamous non-small-cell lung cancer, suggest the results of a head-to-head trial.
› Verified 2 days ago
Richard Kline, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 808-486-6000 | |
Kellie Wo, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 3030, Aiea, HI 96701 Phone: 808-627-3254 | |
Samuel Andrade, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 3030, Aiea, HI 96701 Phone: 808-627-3200 | |
David Lyn Swanson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 808-486-6000 | |
Dr. Agnes Serranilla-sonido, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 3030, Aiea, HI 96701 Phone: 808-627-3254 Fax: 808-627-3265 | |
Nataliya Panova, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 3030, Aiea, HI 96701 Phone: 808-627-3254 | |
Melissa Malia Narvaez Gozun, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 3030, Aiea, HI 96701 Phone: 808-627-3254 |